Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER? -- Ignore unavailable to you. Want to Upgrade?

To: Tupulak who wrote (22)	3/23/1999 12:57:00 PM
From: John Trudeau	Read Replies (2) \| Respond to of 164

Curtis, I spoke with Synsorb's IR person. Patience will definitely be required on this play. It will be at least two years before their Synsorb PK drug is available.... IF all goes well. Similarily, it will be at least 3 years until anything comes of their Oncolytics acquisition. It also sounds like they may be in the middle of doing a financing.... Yikes! around these prices. The only good thing, IMO, is that they believe their Oncolytics cancer product can be protected by patents. I like the company, but I'm not that patient.... Also, I really don't like the fact that recent sales have originated from Yorkton. Yorkton's Feb 99 report states an $11.00 / share target price, yet their house (or someone at their house) is selling into an extremely weak market. Also, SYB's IR person said the target prices have all been revised downward.... I'm bailing, for now. Just too much risk given these time lines. Ouch! Good luck, JT